Carter's, Inc. (CRI) Stock Forecast
CRI analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.62 / 5 from 8 analysts
- Price target
- $40.57 average of analyst targets
- Upside to target
- +29.0% from the latest close
- Next earnings
- October 26, 2026 EPS estimate $0.85
- 52-week range
- $28.54 – $44.37
CRI analyst ratings
8 analystsNumber of analysts at each rating.
CRI price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CRI earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.88 | $0.77 | $0.98 | $0.74 | +18.5% | 8 |
| Current fiscal year (2026) | $3.23 | $2.95 | $3.57 | $3.47 | −6.9% | 8 |
| Next fiscal year (2027) | $3.55 | $3.15 | $4.10 | $3.23 | +10.0% | 8 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CRI revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $752.0M | $746.0M | $760.3M | −0.8% | 7 |
| Current fiscal year (2026) | $2.97B | $2.95B | $2.99B | +2.6% | 7 |
| Next fiscal year (2027) | $3.01B | $2.98B | $3.05B | +1.4% | 7 |
CRI EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CRI revenue: reported and forecast
CRI EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.89 | $0.89 | $0.89 | $0.89 | $0.88 | −1.3% | 3 up · 2 down |
| Current fiscal year (2026) | $3.26 | $3.26 | $3.27 | $3.27 | $3.23 | −1.0% | 4 up · 2 down |
| Next fiscal year (2027) | $3.65 | $3.64 | $3.69 | $3.69 | $3.55 | −2.8% | 2 up · 4 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CRI earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CRI beat in 11 of 12.
What analysts expect from CRI
8 analysts cover Carter's; their consensus rating is buy (3.62 on a 1–5 scale, where 5 is a strong buy). The average price target is $40.57, 29.0% above the latest close of $31.45. Analysts expect earnings of $3.23 per share for 2026, −6.9% from a year earlier. For 2027 the average estimate is $3.55 per share on revenue of $3.0 billion. Carter's beat the EPS estimate in 11 of the last 12 quarters.
Related: CRI income statement, CRI key metrics, CRI chart. See the CRI stock overview for the latest quote and news.
CRI forecast FAQ
What is Carter's's price target?
The average analyst price target for Carter's is $40.57, 29.0% above the latest close of $31.45.
Is Carter's a buy, hold or sell?
Of 8 analysts covering Carter's, 3 rate it a strong buy, 0 a buy, 4 a hold, 1 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Carter's's EPS forecast?
Analysts forecast $3.23 per share for 2026 (range $2.95 to $3.57); for 2027 the estimate is $3.55.
What is Carter's's revenue forecast?
The average revenue estimate for 2026 is $3.0 billion, growth of 2.6%; for 2027 it is $3.0 billion.
When does Carter's report earnings?
Carter's is expected to report results for the quarter ending September 30, 2026 on October 26, 2026; the EPS estimate is $0.85.
Does Carter's usually beat earnings estimates?
Carter's reported EPS at or above the analyst estimate in 11 of the last 12 quarters.